A Study to Evaluate the Effects of Hepatic Impairment on the Pharmacokinetics of Relacorilant
Clinical trial NCT06094725 · COMPLETED
Trial details
- NCT number
- NCT06094725
- Sponsor
- Corcept Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-06
- Primary completion
- 2020-12-14
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.